Overview
Kamal Kishore is an Ophthalmologist in Peru, Illinois. Dr. Kishore is highly rated in 9 conditions, according to our data. His top areas of expertise are Retinal Detachment, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, Late-Onset Retinal Degeneration, and Vitrectomy.
His clinical research consists of co-authoring 51 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3602 Marquette Rd, Peru, IL 61354
4505 N Rockwood Dr Ste 1, Peoria, IL 61615
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Joliet Office
Joseph Civantos is an Ophthalmologist in Joliet, Illinois. Dr. Civantos is highly rated in 33 conditions, according to our data. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, and Diabetic Retinopathy.
Joliet Office
John Pollack is an Ophthalmologist in Joliet, Illinois. Dr. Pollack is highly rated in 25 conditions, according to our data. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), Cone Rod Dystrophy Amelogenesis Imperfecta, and Vitrectomy.
CGH Medical Center
John Hahn is an Ophthalmologist in Sterling, Illinois. Dr. Hahn is highly rated in 21 conditions, according to our data. His top areas of expertise are Cataract, Conjunctivitis (Pink Eye), Glaucoma, and Retinal Artery Occlusion.
Frequently Asked Questions about Dr. Kamal Kishore
How do I make an appointment with Dr. Kamal Kishore?
You can book an appointment with Dr. Kamal Kishore by calling their office at 815-223-7400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Kamal Kishore a top-rated expert for Retinal Detachment?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kamal Kishore is classified as an Distinguished expert for Retinal Detachment, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Kamal Kishore specialize in?
While Dr. Kamal Kishore is a Ophthalmology, they have specific expertise in Retinal Detachment, Age-Related Macular Degeneration (ARMD), and Retinal Artery Occlusion. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.
Does Dr. Kamal Kishore participate in research or clinical trials?
Yes. Dr. Kamal Kishore has published 51 articles and abstracts on conditions like Retinal Detachment. You can view a list of Dr. Kamal Kishore's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Kamal Kishore accept my insurance?
Dr. Kamal Kishore accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 815-223-7400 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Age-Related Macular Degeneration (ARMD)Dr. Kishore isDistinguished. Learn about Age-Related Macular Degeneration (ARMD).
- EndophthalmitisDr. Kishore isDistinguished. Learn about Endophthalmitis.
- Late-Onset Retinal DegenerationDr. Kishore isDistinguished. Learn about Late-Onset Retinal Degeneration.
- Retinal Artery OcclusionDr. Kishore isDistinguished. Learn about Retinal Artery Occlusion.
- Retinal DetachmentDr. Kishore isDistinguished. Learn about Retinal Detachment.
- VitrectomyDr. Kishore isDistinguished. Learn about Vitrectomy.
- Advanced
- Diabetic RetinopathyDr. Kishore isAdvanced. Learn about Diabetic Retinopathy.
- Geographic AtrophyDr. Kishore isAdvanced. Learn about Geographic Atrophy.
- Retinal Vein OcclusionDr. Kishore isAdvanced. Learn about Retinal Vein Occlusion.
- Experienced
- CataractDr. Kishore isExperienced. Learn about Cataract.
- Central Serous ChorioretinopathyDr. Kishore isExperienced. Learn about Central Serous Chorioretinopathy.
- Choroid Plexus CarcinomaDr. Kishore isExperienced. Learn about Choroid Plexus Carcinoma.
- Diabetic Macular Edema (DME)Dr. Kishore isExperienced. Learn about Diabetic Macular Edema (DME).
- GlaucomaDr. Kishore isExperienced. Learn about Glaucoma.
- HyphemaDr. Kishore isExperienced. Learn about Hyphema.